Tag: Automated

Filter Integrity Test Market Worth $82.38 Million By 2026

The global filter integrity test market size is expected to reach USD 82.38 million by 2026 growing at a CAGR of 4.31% during the forecast period, according to a new report by Grand View Research, Inc. The introduction of stringent regulations pertaining to the evaluation of the integrity of filter products has driven the adoption of filter integrity test systems within biopharmaceutical, food & beverages, and other end-use settings. The tests are highly adopted by the aforementioned end-users to ensure the structural integrity of a sterilizing filter in order to meet all regulatory requirements as well as manufacturer’s specifications, which in turn, has spurred the revenue generation in this market.

The availability of fully automated testing systems has provided emerging key players with lucrative growth avenues. Automated systems are portable and easy-to-use and provide reliable data, thereby enable in saving time as well as reducing labor and other handling costs. Furthermore, advancements such as the touch screen user interface simplify the test process and accelerate the testing capabilities.

Numerous incidences of post-use filter failure are detected during the filtration process leading to the removal or reprocessing of filtered products. Implementation of pre-use/post-sterilization integrity testing minimizes such post-use failure detections in the product, consequently improving the quality of filtration. This has further boosted the adoption of such tests in the market.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/filter-integrity-test-market

Further Key Findings from the Report Suggest:

  • High usage rate of bubble point test as a non-destructive method has attributed to the largest revenue share of the bubble point test
  • Pressure hold test is gaining popularity mainly because it eliminates the risk to downstream sterility, and is expected to witness an increase in adoption rate at a lucrative pace
  • High preference as well as the implementation of automated test systems coupled with continuous advancements in product designing, has resulted in the maximum revenue share of this segment
  • Liquid filter integrity test accounted for higher penetration in 2018 due to high adoption of hydrophilic filters in bubble point and forward flow (diffusion) tests
  • Factors such as high demand for single-use products, expansion of contract services, and increasing funds for bioprocessing technology have driven the adoption of test systems in biopharmaceutical & pharmaceutical companies at large scale
  • Mutually beneficial partnerships between the key players and food & beverage producers for improving the quality of food products offer lucrative opportunities for integrity tests in the food & beverage industry
  • North America dominated the global market due to the presence of leading players providing testing systems and stringent government regulations for implementation of tests within multiple industries
  • Asia Pacific is poised to witness the fastest growth as a consequence of the continuous efforts adopted by the local players as well as international players to reinforce their market presence
  • Sartorius AG, PARKER HANNIFIN CORP, Pall Corporation, and Merck KGaA are some key players operating in the filter integrity test market
  • Key vendors are adopting strategic growth initiatives such as novel product developments, partnerships & agreements, and geographical expansion to enhance the market share

Blood Culture Test Market Worth $7.3 Billion by 2026

The global blood culture test market size is expected to reach USD 7.3 billion, at a CAGR of 9.1% by 2026, according to a new report by Grand View Research, Inc. Increasing prevalence of bloodstream infections and infectious diseases is the most significant factor anticipated to propel the growth. Rising demand for advanced diagnostic techniques for the diagnosis of infectious diseases, such as sepsis, is projected to drive the growth. Thus, many manufacturing companies have begun focusing on development of advanced diagnostic instruments and consumables. For instance, Cepheid offers Xpert MRSA/SA assay that aids in accurate detection of SA and MRSA in positive blood culture specimens in about an hour.

Introduction of various government initiatives pertaining to the prevention and control of infections is likely to propel the demand for blood culture tests. According to the Centers for Disease Control and Prevention (CDC), there was 46% decrease in central line-associated bloodstream infections in U.S. between 2008 and 2013, owing to the efforts taken by the U.S. government for the prevention of Hospital-acquired Infections (HAIs).

Click the link below:
https://www.grandviewresearch.com/industry-analysis/blood-culture-tests-market

Further key findings from the report suggest:

  • Conventional blood culture technique was the largest revenue-grossing segment in 2018 owing to increased applications of this method in hospitals, independent clinical laboratories, and pathology laboratories
  • In product segment, consumables accounted for the largest market share in terms of revenue in 2018, due the product applications in diagnostics and research, with repetitive purchase, such as blood culture media, assay, kits, and reagents, adding to the revenue
  • Automated blood culture systems is the fastest growing segment owing to the advantages of automation, such as low chances of error and faster result generation
  • Molecular technology is projected to expand at the highest CAGR over the forecast period, due to rising demand for advanced products by hospitals and laboratories for diagnosis of infectious diseases
  • Bacterial infections accounted for the largest revenue share in 2018, due to the fact that they are the most common cause for infection in the blood
  • Reference laboratories is projected to expand at the highest CAGR during the study period, because there is an increase in outsourcing of blood tests by hospitals to reference laboratories
  • North America accounted for the largest revenue share of the blood culture test market in 2018, due to the presence of well-developed healthcare infrastructure in this region
  • Asia Pacific is anticipated to register the highest CAGR during the forecast period owing to increased focus of government on the prevention of infectious diseases
  • Few key players include Becton, Dickinson and Company; bioMérieux SA; Thermo Fisher Scientific, Inc.; Danaher Corporation; Luminex Corporation; Roche; Bruker Corporation; and Abbott Laboratories.